Merck & Co., Inc.
MRKNYSEHealthcare● Active
$119.52
$-1.27(-1.05%)
Market Cap$295.2B
P/E Ratio—
52W High$125.14
52W Low$76.66
Merck & Co., Inc.（MRK）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MRK · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $18.25B | $17.13B | $0.36B | $14.53B | $12.36B |
| Depreciation & Amort. | $5.84B | $4.50B | $3.87B | $3.91B | $3.21B |
| Stock-Based Comp. | $0.00B | $0.76B | $0.65B | $0.54B | $0.48B |
| Change in Working Capital | ($6.98B) | ($3.67B) | ($2.21B) | ($2.78B) | ($3.84B) |
| Net Cash from Operations | $16.47B | $21.47B | $13.01B | $19.09B | $14.11B |
| Investing Activities | |||||
| Capital Expenditure | ($4.11B) | ($3.37B) | ($3.86B) | ($4.39B) | ($4.45B) |
| Purchases of Investments | ($1.21B) | ($0.52B) | ($0.95B) | ($1.20B) | ($0.00B) |
| Sales of Investments | $1.68B | $0.38B | $1.66B | $0.72B | $1.03B |
| Net Cash from Investing | ($13.74B) | ($7.73B) | ($14.08B) | ($4.96B) | ($16.55B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($5.08B) | ($1.31B) | ($1.35B) | $0.00B | ($0.84B) |
| Dividends Paid | ($8.18B) | ($7.84B) | ($7.45B) | ($7.01B) | ($6.61B) |
| Debt Issued / Repaid | $11.38B | $2.31B | $4.18B | ($2.25B) | $1.63B |
| Net Cash from Financing | ($1.92B) | ($7.03B) | ($4.81B) | ($9.12B) | $2.59B |
| Free Cash Flow | |||||
| Free Cash Flow | $12.36B | $18.10B | $9.14B | $14.71B | $9.66B |
| FCF Margin %(computed) | 19.04% | 28.20% | 15.21% | 24.81% | 19.84% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Merck & Co., Inc.
关于Merck & Co., Inc.（MRK）现金流量表
Merck & Co., Inc. 2025财年经营活动现金流$16.47B，自由现金流$12.36B（FCF利润率19.04%），资本支出($4.11B)。
常见问题
MRK · 4 问Merck & Co., Inc. 2025财年自由现金流$12.36B，同比down31.7%。
MRK free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10